When was Genetesis founded?

Genetesis was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Where is Genetesis located?

Genetesis is headquartered in Mason, United States. It is registered at Mason, Ohio.

Who is the current CEO of Genetesis?

Peeyush Shrivastava of Genetesis. They have also founded 1 company.

How many employees does Genetesis have?

As of Jul 31, 2026, the latest employee count at Genetesis is 6.

Is Genetesis a funded company?

Genetesis is a funded company, having raised a total of $40M across 6 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Oct 31, 2014.

When was the latest funding round of Genetesis?

Genetesis' latest funding was a $***** Series C round on Oct 06, 2022, with participation from 5 investors. Its primary sector is Cardiac and Vascular Disorders. In United States, the Cardiac and Vascular Disorders sector has seen $1.1B in funding in 2026 to date.

Where does Genetesis rank among its competitors?

Genetesis ranks 1st amongst 5 active competitors, of which 2 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was BEIJING X-MAGTECH TECHNOLOGIES, which secured $13.8M in Jul, 2024.

Who are the top competitors of Genetesis?

Genetesis' top competitors include BEIJING X-MAGTECH TECHNOLOGIES, AMCG and MyCardioScan. Among them, BEIJING X-MAGTECH TECHNOLOGIES secured the most recent funding round in July, 2024.

Genetesis - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of a medical imaging device for the diagnosis of cardiac conditions. It offers a medical device called CardioFlux, that uses magnetocardiography (MCG) to measure the natural magnetic fields produced by the heart.

Website: www.genetesis.com
Social
Email ID: *****@genetesis.com
Registered Address: Mason, Ohio

Key Metrics

Founded Year

2013

Location

Mason, United States

Stage

Series C

Total Funding

$40M in 6 rounds

Latest Funding Round

Series C, Oct 06, 2022, $*****

Investors

CincyTech & 19 more

Ranked

1^st among 5 active competitors

Employee Count

6 as on Jul 31, 2026

Similar Companies

BEIJING X-MAGTECH TECHNOLOGIES & 3 more

View Genetesis' full profile

Genetesis is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Genetesis, Inc. CIN: 463652467 , United States, Active	Dec 31, 1999	-	28 (As on Dec 31, 2024)	-

Genetesis has raised a total funding of $40M over 6 rounds. Its first funding round was on Oct 31, 2014. Its latest funding round was a Series C round on Oct 06, 2022 for $*****. 5 investors participated in its latest round. Genetesis has 19 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Genetesis:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 06, 2022	2252062	Series C	4863684	8946943	8084064	3918406
Oct 19, 2021	9165086	Series B	7709176	2981866	6014390	8614380
Apr 23, 2020	3419171	Series B	7757902	3213617	TDK Ventures	CincyTech & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of Genetesis's funding rounds and investors

The founders of Genetesis is Peeyush Shrivastava. Peeyush Shrivastava is the CEO of Genetesis.

Here are the details of Genetesis' key team members:

Peeyush Shrivastava: Co-Founder & CEO of Genetesis.

View details of Genetesis's Founder profiles and Board Members

Genetesis' employee count trend

Genetesis has 6 employees as of Jul 26. Here is Genetesis's employee count trend over the years:

Uncover Genetesis' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Genetesis include BEIJING X-MAGTECH TECHNOLOGIES, AMCG and MyCardioScan. Here is the list of Top 10 competitors of Genetesis, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Genetesis 2013, Mason (United States), Series C	Developer of a medical imaging device for the diagnosis of cardiac conditions	$40M	Mithril, Venture for America & 18 others	43/100
2nd	BEIJING X-MAGTECH TECHNOLOGIES 2020, Haidian (China), Series A	Developer of non-invasive magnetic resonance imaging equipment	$28.7M	IDG Capital, Beijing Robot Industry Fund & 6 others	39/100
3rd	AMCG 2021, South Korea, Unfunded	Manufacturer of cardiac diagnostic systems utilizing magnetocardiography and sensor technology	-	-	16/100
4th	MyCardioScan Sao Paulo (Brazil), Unfunded	Developer of AI-powered cardiac MRI analysis software for early heart disease detection	-	-	16/100
5th	Skidmore Medical 2004, Bristol (United Kingdom), Funding Raised	Developer of diagnostic devices for cardiovascular conditions	-	Altano Capital	15/100